{"id":"W4387952420","doi":"10.1055/s-0043-1771661","title":"Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn’s disease patients with secondary loss of response during ustekinumab maintenance therapy: week 16 results from the phase 3b POWER trial","year":2023,"lang":"en","type":"article","venue":"Zeitschrift für Gastroenterologie","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Maintenance therapy; Internal medicine; Randomized controlled trial; Disease; Chemotherapy; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006538436,0.0003313233,0.0003569695,0.0001179874,0.0001078173,0.00002378566,0.0003686447,0.0001434996,0.000024201],"category_scores_gemma":[0.0004775935,0.0002338916,0.0001238478,0.0001674646,0.0003779237,0.0000262853,0.000177228,0.0002529848,0.000002272192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002173036,"about_ca_system_score_gemma":0.0001943798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003853066,"about_ca_topic_score_gemma":0.00006117758,"domain_scores_codex":[0.9971702,0.0006556906,0.0007155726,0.000648051,0.0003024102,0.0005080673],"domain_scores_gemma":[0.9982947,0.0001317046,0.0004356789,0.0008321045,0.0001644115,0.0001414349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9356776,0.001071711,0.04783299,0.00001976639,0.0001790859,0.0002255753,0.0005483959,0.000195508,0.01172736,0.000002862472,0.0001984434,0.002320694],"study_design_scores_gemma":[0.1398047,0.003393792,0.853818,0.00008679439,0.00002010367,0.000001967455,0.0002150986,0.0000064526,0.002052422,0.000005447243,0.0004483024,0.0001468922],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966765,0.000111774,0.00002139897,0.0002625752,0.0002116868,0.001420215,0.001235048,0.00003170435,0.00002910473],"genre_scores_gemma":[0.9988254,0.0003300373,0.00003020254,0.0001402946,0.00009571166,0.00006348919,0.0004396248,0.00004694796,0.00002833411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.805985,"threshold_uncertainty_score":0.9537824,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01265814090697608,"score_gpt":0.2539851544492528,"score_spread":0.2413270135422767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}